poisar

Stock

Biomerica, Inc. BMRA

$1.58-2.47%

Overview

BMRA market data

Price History

BMRA price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$2.16
Diluted earnings per share over the trailing twelve months.
Beta
0.38
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-96.5%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.45 – $4.60
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $5.1M · P/B 2.10 · P/S 1.18.

Company News

2 captured
8-K filing — BIOMERICA INC (BMRA)SEC EDGAR · Jun 4, 2026, 8:45 PM
Biomerica Enters Into Master Services Agreement With Confidential Life Sciences Company To Develop Proprietary IVD Assays; Engagement Carries Initial Contract Development Target Fee Of Over $1.75MBenzinga · May 28, 2026, 12:30 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock